Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mastocytosis × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 11 Breast Neoplasms 8 Prostatic Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Melanoma 5 COVID-19 4 Multiple Myeloma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Recurrence 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Leukemia 2 Glioblastoma 2 Cholangiocarcinoma 2 Adenocarcinoma of Lung 2 Adenocarcinoma 2 Urologic Diseases 1 Untreated Resectable Pancreatic Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma 1

Interventions

masitinib 4 Imatinib Mesylate 3 midostaurin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Sodium Chloride 1 Single-Cell Gene Expression Analysis 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Injections 1 Hydroxychloroquine 1 Dasatinib 1 Cyclophosphamide 1 Cromolyn Sodium 1 Cladribine 1 Busulfan 1 BNT162 Vaccine 1 AK002 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05084872 2021-10-20

HCQMa

University Hospital, Toulouse

Phase 2/3 Unknown

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡